Form 4 · Filed Jul 9, 2026, 08:45 PM UTC
VERA/Vera Therapeutics, Inc.
Fordyce Marshall — PRESIDENT AND CEO
AI Thesis
A thesis has not been generated for this filing yet — usually available within 60 seconds of EDGAR publication. Refresh shortly.
Research signal, not investment advice. Form 4 AI surfaces SEC filings and applies an analytical layer — it does not predict prices or recommend trades. Past performance does not guarantee future results. See methodology and public track record for how scores are computed.
Transactions
4 rows| Date | Code | Direction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Jul 7, 2026 | S | sell | 1,000 | $41 | $40,776 | 197,244 |
| Jul 7, 2026 | S | sell | 32,550 | $42 | $1,369,496 | 164,694 |
| Jul 7, 2026 | S | sell | 10,500 | $43 | $450,007 | 154,194 |
| Jul 7, 2026 | S | sell | 2,200 | $44 | $95,908 | 151,994 |
Source: SEC EDGAR raw filing ↗ · Accession 0001859453-26-000010